NuCel®, amniotic tissue-derived cells for treatment of degenerative disc disease
NuCel® is an allograft comprised of amniotic membrane along with amniotic fluid cells, indicated for treatment of two or three level degenerative disease of the lumbar spine. Two clinical trials are being conducted to assess efficacy and safety of NuCel® in degenerative lumbar spine disease patients, undergoing standard spinal fusion surgery.
Read More
Product Information for
NuCel®, amniotic tissue-derived cells for treatment of degenerative disc disease
Links related to the product - may include a range of information sources (e.g., press releases, websites, patents) related to the specific cell therapy application.
Access to this data is limited to
LifeMap Discovery Registered users onlySign in for full access
Access to this data is limited to
LifeMap Discovery Registered users onlySign in for full access
Access to this data is limited to
LifeMap Discovery Registered users onlySign in for full access